Impact of Early Relative Dose Intensity on Survival in Patients Receiving Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Japanese Real-World Multicenter Study.
- DOI
- 10.1111/iju.70523
- Published
- 2026 Jun
- Container
- International journal of urology : official journal of the Japanese Urological Association
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/iju.70523,
title = {Impact of Early Relative Dose Intensity on Survival in Patients Receiving Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Japanese Real-World Multicenter Study.},
author = {Endo Y and Sakura Y and Kaneko G and Hayakawa N and Ikarashi D and Yamashita R and Shirotake S and Obara W and Kondo Y and Kikuchi E},
year = {2026},
journal = {International journal of urology : official journal of the Japanese Urological Association},
doi = {10.1111/iju.70523},
url = {https://doi.org/10.1111/iju.70523}
}RIS
TY - JOUR TI - Impact of Early Relative Dose Intensity on Survival in Patients Receiving Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Japanese Real-World Multicenter Study. AU - Endo Y AU - Sakura Y AU - Kaneko G AU - Hayakawa N AU - Ikarashi D AU - Yamashita R AU - Shirotake S AU - Obara W AU - Kondo Y AU - Kikuchi E PY - 2026 JO - International journal of urology : official journal of the Japanese Urological Association DO - 10.1111/iju.70523 UR - https://doi.org/10.1111/iju.70523 ER -
APA
Y, E., Y, S., G, K., N, H., D, I., R, Y., S, S., W, O., Y, K., & E, K. (2026). Impact of Early Relative Dose Intensity on Survival in Patients Receiving Enfortumab Vedotin for Metastatic Urothelial Carcinoma: A Japanese Real-World Multicenter Study.. International journal of urology : official journal of the Japanese Urological Association. https://doi.org/10.1111/iju.70523
Source records
- pubmed · retrieved 2026-09-26T08:28:32.635Z